siRNA, Anti-GTF3A, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT06935WQ-2OMe)

The product SIRGT06935WQ-2OMe is a type of small interfering RNA (siRNA) that targets GTF3A gene and regulates the expression of gene. The siRNA interferes with the expression of GTF3A gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_002097.2
Alternative Names AP2; TFIIIA
Related Diseases Thrombasthenia, Prostate Carcinoma In Situ
Purification HPLC
Target Gene
Gene ID 2971
Uniprot ID Q92664
Sub Cat Target Species Modification Scale  
SIRGT07935WQ-2F GTF3A Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT08935WQ-2MOE GTF3A Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT09935WQ-LNA GTF3A Human Locked Nucleic Acid (LNA) Inquiry
SIRGT06935WQ-RB GTF3A Human Ribo-modified Inquiry
SIRGT07935WQ-BB GTF3A Human Backbone-modified Inquiry

Related Products